We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Newly Designed LVAD Helps Ailing Hearts Beat Better

By HospiMedica staff writers
Posted on 30 Apr 2007
A new implantable pulsatile left ventricular-assist device (LVAD) provides more physiologic assistance to patients suffering from severe heart failure. More...


The BestBeat system operates automatically in synchronous counterpulsation with the native left ventricle, thereby unloading the heart and optimizing tolerance to exercise and increased metabolic needs. The system allows variation of the left ventricular (LV) afterload, adapting the degree of assistance to the patient's needs while synchronous counterpulsation and full-flow through the device are maintained. These characteristics make the system especially suitable as both a transplant bridge for chronic assistance and as a recovery bridge, since the counterpulsation allows the cardiac muscle to rest completely. The adjustable load allows the clinician to control the weaning phase, maintaining synchronous counterpulsation without decreasing blood flow.

The small, fully implantable device weighs only 535 g, is built of bio- and hemo-compatible materials such as titanium and polyurethane, and provides a pump flow of up to 8 l/min. The durability of the system is ensured by an actuation system based on an advanced ball screw technology. The control and monitoring unit is controlled by a user-friendly software interface that runs on a standard laptop, which allows real-time device monitoring and device history querying, and a powerful battery worn on a strap powers the system. The BestBeat system is being developed by NewCorTec (Rome, Italy) with technical assistance by et medical devices (Cavareno, Italy). The BestBeat system is an investigational device currently undergoing clinical trials in France and Germany.

"BestBeat does justice to its name because it adapts to the natural heartbeat of the patient far better than previous LVADs, leading amongst other things to a better recovery of the diseased heart,” said Dr. Aly El-Banayosy, director of the VAD and artificial heart ward at the Heart and Diabetes Center NRW (Bad Oeynhausen, Germany), who implanted the device for the first time ever in a 68-year-old man in March 2007.


Related Links:
NewCorTec
et medical devices
Heart and Diabetes Center NRW

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.